Inotuzumab Ozogamicin Injection

225 interactions 104 cited references
Also sold as: Besponsa Besponsa®
About Inotuzumab Ozogamicin Injection

Inotuzumab ozogamicin injection is used to treat certain acute lymphoblastic leukemia (ALL; a type of cancer that begins in the white blood cells) in adults who have not responded to previous cancer treatments. Inotuzumab ozogamicin injection is in a class of medications called monoclonal antibodies. It works by activa… Read the full Inotuzumab Ozogamicin Injection drug information page →

Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Aug 9, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Major

Inotuzumab Ozogamicin Injection Adagrasib Krazati An increased risk of QT interval prolongation, torsade de pointes, polymorphic ventricular tachycardia, other serious arrhythmias Details Inotuzumab Ozogamicin Injection Adenovirus Vaccine Type 4, Live An increased risk of infection by the live vaccine Details Inotuzumab Ozogamicin Injection Adenovirus Vaccine Type 7, Live An increased risk of infection by the live vaccine Details Inotuzumab Ozogamicin Injection Alfuzosin UroXatral Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Amiodarone Nexterone Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Amisulpride Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Inotuzumab Ozogamicin Injection Amitriptyline Elavil Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Anagrelide Agrylin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Apomorphine Apokyn Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Aripiprazole Abilify Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Aripiprazole Lauroxil Aristada Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Arsenic Trioxide Trisenox Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Artemether An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Asenapine Saphris Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Astemizole Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Atazanavir Reyataz Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Azithromycin AzaSite Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Bedaquiline Sirturo Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Buprenorphine Belbuca An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Buserelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Ceritinib Zykadia An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Chloroquine Aralen® Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Chlorpromazine Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Cholera Vaccine Ipol An increased risk of infection by the live vaccine Details Inotuzumab Ozogamicin Injection Ciprofloxacin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Citalopram Celexa Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Clarithromycin Biaxin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Clomipramine Anafranil Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Clothiapine Increased risk of cardiac arrhythmias Details Inotuzumab Ozogamicin Injection Clozapine Clozaril Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Crizotinib Xalkori Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Cyclobenzaprine Amrix Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dabrafenib Tafinlar Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Dasatinib Phyrago Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Degarelix Firmagon Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Delamanid Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Desflurane Suprane An increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Desipramine Norpramin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Deslorelin Increased risk of QT interval prolongation Details Inotuzumab Ozogamicin Injection Deutetrabenazine Austedo Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.